The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nasacort Allergy 55 micrograms/dose nasal spray, suspension

Opella Healthcare France SAS T/A SanofiPA23180/001/002

Main Information

Trade NameNasacort Allergy 55 micrograms/dose nasal spray, suspension
Active SubstancesTriamcinolone acetonide
Dosage FormNasal spray, suspension
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/001/002

Group Information

ATC CodeR01AD Corticosteroids
R01AD11 triamcinolone


License statusAuthorised
Licence Issued09/12/2011
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back